European Journal of Neurology

Article	Citations
	176
Issue Information	109
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	105
Central nervous system crystal‐storing histiocytosis: A case report and literature review	99
Lessons from the past to understand the future	98
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	94
Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage	86
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	83
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	83
Concerns Regarding “Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy”	71
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	70
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	68
	63
Long‐Term Improvements Following Initial Migraine Response in Eptinezumab‐Treated Participants With Migraine for Whom 2–4 Prior Preventive Treatments Have Failed	63
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	60
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	59
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy	56
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	54
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	54
ePoster	54
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	54
	54
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	53
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	52
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	51

Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	50
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	46
Comparative features and outcomes of major neurological complications of COVID‐19	46
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	45
Markers of Giant Cell Arteritis in Patients Presenting With Ischemic Stroke: A Scoping Review	45
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics	45
The effect of influenza vaccination on the rate of dementia amongst older adults	45
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	44
Prevalence and Impact of Probable REM Sleep Behavior Disorder in Essential Tremor: A Multicenter Cross‐Sectional Study	43
1‐Year Clinical Outcome Post‐Myasthenic Crisis: A Multicenter Prospective Study in China	43
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	43
Prioritization process for European Academy of Neurology clinical practice guidelines	41
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	41
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	41
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	40
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	40
Issue Information	40
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	39
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	39
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis	39
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	39
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	38
Issue Information	38
	38
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	38
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	38
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	38
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	37
Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters	36
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	36
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	35
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	35
Issue Information	35
IgG4‐Related Disease Associated With Myotonic Dystrophy Type 2	34
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	34
Abnormal Sleep in Chronic Inflammatory Demyelinating Polyneuropathy	34
Focused Workshops	33
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	33
Generative artificial intelligence in neurology: Opportunities and risks	33
Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals	32
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	31
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	31
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	31
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	31
Risk of New‐Onset Myasthenia Gravis Following COVID ‐19 Infection and Vaccination: A Population‐Based Case–Control Study	31
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	30
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	30
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	30
Issue Information	30
Renal Cell Carcinoma With Unknown Primary in the Femur: The Loch Ness Monster?	30

Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	30
Oral Presentations	29
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	29
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	29
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door‐In‐Door‐Out Times in Thrombectomy Patients: A Retrospective Analysis	28
Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	28
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	28
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	28
Neurology Undergraduate Medical Education: A Scoping Review	28
Arterial Stiffness, Central Blood Pressure, and the Risk of Incident Stroke in Hypertensive Adults	28
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	28
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	28
Letter to the Editor: “Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension”	28
Corrigendum to “Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study”	28
A Novel 3D Semi‐Automated Full Quantification Technique for Detection of Intraneural Phospho‐α‐Synuclein in Skin Biopsies	27
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	27
The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high‐resolution imaging	27
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	27
Antipsychotics and Their Association With Long‐Term Outcomes in Young Ischemic Stroke Patients	27
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	27
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	27
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	27
Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study	27
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	27
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	26
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	26
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	26
Symposia	26
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	26
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	25
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	25
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	25
Data‐Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis	25
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	25
Development of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis	25
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	25
Plenary Sessions	24
Issue Information	24
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	24
	24
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis	24
Cardioembolic Breakthrough Stroke: When Anticoagulation Fails, Is Left Atrial Appendage Closure the Next Step?	24
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	24
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	24
Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants	23
Glutamine Metabolism and Metabolic Profiling Using 7 T CRT‐FID MRSI in Focal Epilepsy	23
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	23
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	23
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	23
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	23
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	23
Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb‐Girdle Muscular Dystrophy in an Isolated Uruguayan Population	23
Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	23
Combined Brain‐Cardiac CT in Ischemic Stroke: Unveiling Atrial Markers Linked to Large Vessel Occlusion in AF Patients	23
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	22
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	22
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	22
Epilepsy Management in Transgender Population: More Research for Better Treatment	22
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	22
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	22
Structural Alterations Associated With Cardiovascular Autonomic Failure in Multiple System Atrophy	22
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	22
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	22
Clinical presentation and neural correlates of stroke‐associated spatial delusions	21
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers	21
Confirmed disability progression as a marker of permanent disability in multiple sclerosis	21
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	21
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	21
Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	21
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	21
Use of antihypertensive medication and formation of de novo intracranial aneurysms	21
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	21
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	21
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	21
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	20
The many faces of globular glial tauopathy: A clinical and imaging study	20
Latency of poststroke epilepsy can predict drug resistance	20
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	20
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	20
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	20

Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	20
Association between choroid plexus volume and cognition in Parkinson disease	20
The spectrum of central nervous system involvement in Whipple's disease	20
Post‐ COVID ‐Syndrome Patients Might Overestimate Own Cognitive Impairment	20
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	19
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	19
Staging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA ‐Squared Scale	19
ePresentations	19
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	19
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	19
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	19
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	19
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	19
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	19
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	19
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	19
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	19
A Real‐World Study of CGRP Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment Adherence	19
Diagnostic Yield of Anti‐Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis	19
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	18
Plenary Symposium	18
Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk	18
Special Sessions	18
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	18
Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review	18
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	18
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	18
Issue Information	18
Giancarlo COMI (1947–2024)	18
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	18
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	18
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	18
Sex differences in early‐onset Alzheimer's disease	18
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	18
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	18
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	18
Symposia	18
Clinical autonomic nervous system laboratories in Europe	18
The effect of head‐down tilt in experimental acute ischemic stroke	17
Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients	17
Global Health Inequalities in the Burden of Ischemic Stroke From 1990 to 2021	17
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	17
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	17
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	17
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	17
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin Intolerance	17
Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy	17
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample	17
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	17
Clinical outcomes of delayed mechanical thrombectomy: Descriptive analysis and development of a screening tool	16
Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study	16
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	16
	16
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	16
	16
Long‐Term Effectiveness of Early Versus Late Microvascular Decompression for Trigeminal Neuralgia Secondary to Arterial Compression	16
Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study	16
Concurrent Sporadic Late‐Onset Nemaline Myopathy and an Excessive Glycogen Accumulation Associated With Monoclonal Gammopathy	16
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	16
Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis	16
Focused Workshops	16
Thank You to Our Peer Reviewers in 2024	16
Parkinson disease following COVID‐19: Report of six cases	16
	16
Central nervous system cavernous malformations: cross‐sectional study assessing rebleeding risk after a second haemorrhage	15
Correction to “Tirofiban Benefits the Outcome of Stroke Patients With Large Artery Atherosclerosis Achieving Full Reperfusion and High NIHSS Scores”	15
The first European Academy of Neurology (EAN) Science School: shaping the next generation of translational neurologists	15
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles	15
Comment on “Variation in Repeated Handgrip Strength Testing Indicates Submaximal Force Production in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”	15
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomiz	15
The 20th anniversary of the first clinical use of Stalevo®	15
Association Between Migraine and Periodontitis: A Systematic Review and Meta‐Analysis	15
Incidence of Guillain–Barré syndrome following SARS‐CoV ‐2 immunization: Analysis of a nationwide	15
Olfactory Dysfunction and/or RBD for Mapping Parkinson's Disease Subtypes?	15
Prognostic value of glycemic gap in patients with spontaneous intracerebral hemorrhage	15
	15
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy	15
	15
GLP‐1 Agonists as Potential Neuromodulators in Development of Parkinson's Disease: A Nationwide Cohort Study	15
Prognostic Value of Cerebral Hemodynamics Assessment on 24‐h Transcranial Color‐Coded Doppler Following a Successful Thrombectomy	15
Early predictors of dysphagia in ischaemic stroke patients	15
Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts	15
The rise and fall of Queckenstedt's test between 1916 and 1970, a milestone in spinal cord diagnostics and why it matters	15
Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy	15
Shoulder‐Touch test to reveal incongruencies in persons with functional motor disorders	15
Epilepsy Stands Nearby: A Pilot CT Perfusion Study on Post‐Stroke Non‐Convulsive Status Epilepticus	15
GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration	15
Joint Modelling of Growth and Motor Function Centiles in Corticosteroids Treated Boys With Duchenne Muscular Dystrophy	15
Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke	15
Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease	15
Greek Registry for Amyotrophic Lateral Sclerosis (ALS‐GR): An Observational Cohort of Individuals With ALS Across 11 Specialized Centers in Greece	15
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study	15
Migraine worsening after COVID‐19 and COVID‐19 vaccination: Are we facing a nocebo effect?	14
Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study	14
Symposia	14